OFFICIAL STOCK MARKET AND ECONOMY THREAD VOL. A NEW CHAPTER

Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate

  • Phase 1 portion of the Phase 1/2 clinical trial evaluated two doses of Novavax’ COVID-19 vaccine across two dose levels (5 and 25 µg) in 131 healthy adults ages 18-59 years
  • NVX-CoV2373 was generally well-tolerated and had a reassuring safety profile
  • The vaccine induced neutralization titers in 100% of participants
    • Both 5 µg and 25 µg adjuvanted doses generated peak geometric mean titer (GMT) greater than 1:3,300
  • Matrix-M™ adjuvant induced robust polyfunctional CD4+ T cell responses
 
Not going to celebrate this NKLA drop yet. Who knows what'll happen between now and market opening.
 
We back $160 range:ohwell:
ngl...my heart sank to the floor
BTFD always for NVAX

Glad I played it.. been watching it since you said some back like $100 dollars ago it just kept running and I always felt like it was to high to jump in but then it kept going, so when I see it pull back like that I kinda felt like it was gonna fill back in and decided to take a chance. Now I'll be holding it see what happens.
 
Back
Top Bottom